Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes

Journal of NeuroVirology

Volumn 16, Issue 3, 2010, Pages 203-207

  Mori, Isamu ^a  

^a SHUBUN UNIVERSITY   (Japan)

Author keywords

Accessory genes; Amyloid ; Central nervous system; Herpes simplex virus type 1; Host responses; Neural transport

Indexed keywords

LATENCY ASSOCIATED PEPTIDE; PROTEIN UL56; PROTEIN US11; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

AGED; ALZHEIMER DISEASE; BRAIN INFECTION; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNE RESPONSE; NERVOUS SYSTEM; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SHORT SURVEY; VIRUS TRANSMISSION;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; ENCEPHALITIS, HERPES SIMPLEX; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS;

HUMAN HERPESVIRUS 1;

EID: 77953177102     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550281003739040     Document Type: Short Survey

References (49)

1. Benetti L, Roizman B (2004). Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc Natl Acad Sci USA 101: 9411-9416.
2. Cartier A, Broberg E, Komai T, Henriksson M, Masucci MG (2003). The herpes simplex virus-1 US3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B. Cell Death Differ 10: 1320-1328.
3. Cassady KA, Gross M (2002). The herpes simplex virus type 1 US11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain. J Virol 76: 2029-2035.
4. Chee AV, Lopez P, Pandolfi PP, Roizman B (2003). Pro-myelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J Virol 77: 7101-7105.
5. Conrady CD, Drevets DA, Carr DJ (2010). Herpes simplex virus 1 (HSV-1) infection of the nervous system: Is an immune response a good thing? J Neuroimmunol 220: 1-9.
6. Cribbs DH, Azizeh BY, Cotman CW, LaFerla FM (2000). Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to the Alzheimer's Ab peptide. Biochemistry 39: 5988-5994.
7. Daubeuf S, Singh D, Tan Y, Liu H, Federoff HJ, Bowers WJ, Tolba K (2009). HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 113: 3264-3275.
8. Feldman LT, Ellison AR, Voytek CC, Yang L, Krause P, Margolis TP (2002). Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci USA 99: 978-983.
9. Hamza MA, Higgins DM, Feldman LT, Ruyechan WT (2007). The latency-associated transcript of herpes simplex virus type 1 promotes survival and stimulates axonal regeneration in sympathetic and trigeminal neurons. J NeuroVirol 13: 56-66.
10. 1 34.5 protein of herpes simplex virus 1 complexes with protein phos-phatase 1a to dephosphorylate the a subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 94: 843-848.
11. Hickey WF (2001). Basic principles of immunological surveillance of the normal central nervous system. Glia 36: 118-124.
12. Hüfner K, Derfuss T, Herberger S, Sunami K, Russell S, Sinicina I, Arbusow V, Strupp M, Brandt T, Theil D (2006). Latency of alpha-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J Neuropathol Exp Neurol 65: 1022-1030.
13. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997). Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349: 241-244. (Pubitemid 27050990)
14. Itzhaki RF, Wozniak MA (2008). Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimer's Dis 13: 393-405.
15. Itzhaki RF, Cosby SL, Wozniak MA (2008). Herpes simplex virus type 1 and Alzheimer̀s disease: the autophagy connection. J NeuroVirol 14: 1-4.
16. Jerome KR, Chen Z, Lang R, Torres MR, Hofmeister J, Smith S, Fox R, Froelich CJ, Corey L (2001). HSV and glycoprotein J Inhibit caspase activation and apoptosis induced by granzyme B or Fas. J Immunol 167: 3928-3935.
17. Klapper PE, Cleator GM, Longson M (1984). Mild forms of herpes simplex encephalitis. J Neurol Neurosurg Psychiatr 47: 1247-1250.
18. Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL (2008). Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
19. Leib DA, Alexander DE, Cox D, Yin J, Ferguson TA (2009). Interaction of ICP34.5 with Beclin 1 modulates herpes simplex virus type 1 pathogenesis through control of CD4+ T-cell responses. J Virol 83: 12164-12171.
20. Li S, Carpenter D, Hsiang C, Wechsler SL, Jones C (2010). Herpes simplex virus type 1 latency-associated transcript inhibits apoptosis and promotes neurite sprouting in neuroblastoma cells following serum starvation by maintaining protein kinase B (AKT) levels. J Gen Virol 91: 858-866.
21. Lin R, Noyce RS, Collins SE, Everett RD, Mossman KL (2004). The herpes simplex virus ICP0 RING finger domain inhibits IRF3-and IRF7-mediated activation of interferon-stimulated genes. J Virol 78: 1675-1684.
22. Lubinski JM, Jiang M, Hook L, Chang Y, Sarver C, Mastellos D, Lambris JD, Cohen GH, Eisenberg RJ, Friedman HM (2002). Herpes simplex virus type 1 evades the effects of antibody and complement in vivo. J Virol 76: 9232-9241.
23. McGraw HM, Awasthi S, Wojcechowskyj JA, Friedman HM (2009). Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us 9. J Virol 83: 8315-8326.
24. McGraw HM, Friedman HM (2009). Herpes simplex virus type 1 glycoprotein E mediates retrograde spread from epithelial cells to neuritis. J Virol 83: 4791-4799.
25. Mori I, Kimura Y, Naiki H, Matsubara R, Takeuchi T, Yokochi T, Nishiyama Y (2004). Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease. J Med Virol 73: 605-611.
26. Mori I, Nishiyama Y, Yokochi T, Kimura Y (2005). Olfactory transmission of neurotropic viruses. J NeuroVirol 11: 129-137.
27. Mori I, Nishiyama Y (2006). Accessory genes define the relationship between the herpes simplex virus and its host. Microb Infect 8: 2556-2562.
28. Mulvey M, Camarena V, Mohr I (2004). Full resistance of herpes simplex virus type 1-infected primary human cells to alpha interferon requires both the Us11 and g134.5 gene products. J Virol 78: 10193-10196.
29. Nishiyama Y (2004). Herpes simplex virus gene products: the accessories reflect her lifestyle well. Rev Med Virol 14: 33-46.
30. Orvedahl A, Alexander D, Tallóczy Z, Sun Q, Wei Y, Zhang W, Burns D, Leib DA, Levine B (2007). HSV-1 ICP 34.5 confers neurovirulence by targeting the Beclin 1 autop-hagy protein. Cell Host Microbe 15: 23-35.
31. Peng W, Henderson G, Inman M, BenMohamed L, Perng G-C, Wechsler SL, Jones C (2005). The locus encompassing the latency-associated transcript of herpes simplex virus type 1 intereferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal ganglia of acutely infected mice. J Virol 79: 6162-6171.
32. Peri P, Mattila RK, Kantola H, Broberg E, Karttunen HS, Waris M, Vuorinen T, Hukkanen V (2008). Herpes simplex virus type 1 Us3 gene deletion influences toll-like receptor responses in cultured monocytic cells. Virol J 5: 140-150.
33. Shen W, Sa e Silva M, Jaber T, Vitvitskaia O, Li S, Henderson G, Jones C (2009). Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis. J Virol 83: 9131-9139.
34. Sloan DD, Zahariadis G, Posavad CM, Pate NT, Kussick SJ, Jerome KR (2003). CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J Immunol 171: 6733-6741.
35. Smith C, Lachmann RH, Efstathiou S (2000). Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system. J Gen Virol 81: 649-662.
36. Steiner I, Mador N, Reibstein I, Spivack JG, Fraser NW (1994). Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol Appl Neurobiol 20: 253-260.
37. Taddeo B, Zhang W, Roizman B (2006). The UL41 protein of herpes simplex virus 1 degrades RNA by endonu-cleolytic cleavage in absence of other cellular and viral proteins. Proc Natl Acad Sci USA 103: 2827-2832.
38. Tallóczy Z, Virgin IV HW, Levine B (2006). PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2: 24-29.
39. Theil D, Horn AK, Derfuss T, Strupp M, Arbusow V, Brandt T (2004). Prevalence and distribution of HSV-1, VZV, and HHV-6 in human cranial nerve nuclei III, IV, VI, VII, and XII. J Med Virol 74: 102-106.
40. Tomazin R, Hill AB, Jugovic P, York I, van Endert P, Ploegh HL, Andrews DW, Johnson DC (1996). Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15: 3256-3266.
41. Trgovcich J, Johnson D, Roizman B (2002). Cell surface major histocompatibility complex class II proteins are regulated by the products of the g134.5 and UL41 genes of herpes simplex virus 1. J Virol 76: 6974-6986.
42. Umbach JL, Nagel MA, Cohrs RJ, Gilden DH, Cullen BR (2009). Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia. J Virol 83: 10677-10683.
43. Valyi-Nagy T, Olson SJ, Valyi-Nagy K, Montine TJ, Dermody TS (2000). Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology 278: 309-321.
44. Wasling P, Daborg J, Riebe I, Andersson M, Portelius E, Blennow K, Hanse E, Zetterberg H (2009). Synaptic retrogenesis and amyloid-beta in Alzheimer's disease. J Alzheimer's Dis 16: 1-14.
45. Wojtowicz WM, Farzan M, Joyal JL, Carter K, Babcock GJ, Israel DI, Sodroski J, Mirzabekov T (2002). Stimulation of enveloped virus infection by b-amyloid fibrils. J Biol Chem 38: 35019-35024.
46. Wozniak MA, Shipley SJ, Combrinck M, Wilcock Gk, Itzhaki RF (2005). Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. J Med Virol 75: 300-306.
47. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB (2007). Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett, 429: 95-100.
48. Wozniak MA, Mee AP, Itzhaki RF (2009a). Herpes simplex virus type 1 DNA is located within Alzhermer's disease amyloid plaques. J Pathol 217: 131-138.
49. Wozniak MA, Frost AL, Itzhaki RF (2009b). Alzheimer's disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimer's Dis 16: 341-350.